Forward genetic screens with ENU (N-ethyl-N-nitrosourea) mutagenesis can facilitate gene discovery, but mutation identification is often difficult. We present the first study in which an ENUinduced mutation was identified by massively parallel DNA sequencing. This mutation causes heterotaxy and complex congenital heart defects and was mapped to a 2.2-Mb interval on mouse chromosome 7. Massively parallel sequencing of the entire 2.2-Mb interval identified 2 single-base substitutions, one in an intergenic region and a second causing replacement of a highly conserved cysteine with arginine (C193R) in the gene Megf8. Megf8 is evolutionarily conserved from human to fruit fly, and is observed to be ubiquitously expressed. Morpholino knockdown of Megf8 in zebrafish embryos resulted in a high incidence of heterotaxy, indicating a conserved role in laterality specification. Megf8 C193R mouse mutants show normal breaking of symmetry at the node, but Nodal signaling failed to be propagated to the left lateral plate mesoderm. Videomicroscopy showed nodal cilia motility, which is required for left-right patterning, is unaffected. Although this protein is predicted to have receptor function based on its amino acid sequence, surprisingly confocal imaging showed it is translocated into the nucleus, where it is colocalized with Gfi1b and Baf60C, two proteins involved in chromatin remodeling. Overall, through the recovery of an ENU-induced mutation, we uncovered Megf8 as an essential regulator of left-right patterning.
T
he power of forward genetic screens is well illustrated by the remarkable success of the Drosophila chemical mutagenesis screen used to dissect the genetic pathways specifying the segmental body plan (1) . This study elegantly showed the efficacy of phenotype driven mutagenesis screens in the systematic analysis of complex biological processes regulating developmental patterning. To elucidate the genetic basis for congenital heart disease, we pursued a high throughput mouse ENU mutagenesis screen using noninvasive fetal echocardiography for cardiovascular phenotyping. ENU is a potent mutagen ideally suited for the production of human disease models in mice, because it predominantly generates point mutations, which are often associated with human diseases. More than 13,000 mouse fetuses were ultrasound interrogated, with 4% of the fetuses showing some evidence of cardiac defects (2, 3) . This highly efficient cardiovascular phenotyping protocol suggests the possibility of a saturation mutagenesis screen.
The recovery of ENU-induced mutations in mice traditionally entails breeding the mutation generated in one inbred strain into a different inbred strain background, thereby allowing the use of polymorphic DNA markers to map the mutation. Genome scanning of many meiotic recombinants with such polymorphic DNA markers can eventually reduce the map interval to Ͻ1 Mb, when sequencing of candidate genes becomes more practical. This traditional approach for mutation recovery is costly and time consuming, and the mutation may be missed in regions with incomplete genome annotation. However, with rapid advances in a new generation of high throughput DNA sequencing technologies (4-6), rapid and low cost sequencing may greatly facilitate mutation recovery from mutagenesis screens. These new sequencing technologies have already proven useful for addressing a wide range of biological questions, from de novo sequencing of microorganisms (7), cancer mutation discovery (8) , gene expression profiling (9) to epigenetic regulation (10) .
In this study, we used massively parallel sequencing to recover an ENU-induced mutation causing a single-ventricle spectrum of complex structural heart defects recovered in our mouse fetal echocardiography screen (11) . This mutant exhibits transposition of the great arteries, randomized left-right cardiopulmonary and visceral organ situs, a constellation of phenotype referred to as heterotaxy. This mutant also exhibits preaxial polydactyly. We mapped this mutation to a 2.2-Mb interval on mouse chromosome 7. Massively parallel DNA sequencing of the entire 2.2-Mb critical region revealed the underlying genetic lesion as a point mutation in a highly conserved gene, Megf8. Megf8 is expressed ubiquitously, and plays an essential role in left-right patterning through the regulation of Nodal signaling. Overall, through the recovery of an ENU-induced mutation, we uncovered Megf8 as an essential regulator of left-right patterning.
Results

Recovery of Megf8 Mutation.
A recessive mutation was previously recovered exhibiting a single-ventricle spectrum of complex congenital heart defects associated with heterotaxy. Typically these mutants exhibited thoracoabdominal organ situs anomalies that included dextracardia/mesocardia, right pulmonary isomerism, transposition of the great arteries, abnormal pulmonary venous connections, right-sided stomach and asplenia/ polysplenia (Fig. S1 A-C) (11) . We reported the mapping of this mutation to a 3.3-Mb interval on mouse chromosome 7. With analysis of a total of 142 meiotic recombinants, we narrowed the map interval to a 2.2-Mb critical region between markers D7Mit192-SNP rs13460395 (Table S1 ). Exon sequencing of a number of potential candidates showed no mutation. Because the mapped genomic interval is gene dense, systematic resequencing of all coding exons was impractical.
To examine the feasibility of using massively parallel DNA sequencing to recover the mutation in this genomic interval, we constructed a BAC library containing genomic DNA from the mutant and assembled a 10-fold redundant BAC contig spanning the 2.2-Mb critical region (Fig. S2) . From this BAC contig, a minimum tiling path of 15 BACs was delineated (Fig. 1A and Fig.  S2 ). These were pooled and sequenced with 70-fold coverage by massively parallel sequencing. A total of 303 Mb of sequences were generated. Reads were aligned using BLAT to the C57BL/6J reference sequence, the strain background in which the mutation was generated, and potential SNPs were identified as mismatches within the alignments. Filtering for a minimum depth of 5 reads and at least 70% of aligned reads containing the mismatch identified 10 putative variants. All 10 putative mutations were independently assessed by Sanger sequencing, with 2 (26113522 and 26630591) subsequently being sequence confirmed. One mutation was a single base change of a C to A in a non conserved intergenic region, and a second T to C substitution was identified causing a missense mutation (C193R) in the gene Megf8 (Fig. 1 A) .
The point mutation in the intergenic region resides in a repetitive element that is not conserved, even between mouse and rat. Hence, this intergenic mutation is unlikely to be deleterious. In contrast, Megf8 encodes a well-conserved protein of 2,789 aa (GenBank EU723517). Orthologs are found in many other species, including human, zebrafish and Drosophila (Fig. 1B) . The SMART domain tool (12) predicts Megf8 contains multiple EGF, EGF-like, calcium-binding EGF-like and laminin-type EGF-like repeats, kelch domains, plexin repeats, and a CUB and transmembrane domain (Fig. 1B) Tables S2 and S3 ). Among the zebrafish embryos with discordant situs, 10% showed reverse heart looping, and 59% had abnormal or no looping. The latter embryos often exhibited a shortened heart tube ( Fig. 2C ), indicative of a role for Megf8 in cardiac morphogenesis (11) . Approximately half of the embryos with abnormal heart looping showed reverse looping of the gut. This same constellation of situs defects was observed with 2 independent splice-blocking morpholinos (Fig. S3) . These results confirm Megf8 is indispensable for left-right patterning. The recapitulation of the mouse heterotaxy phenotype with Megf8 morpholino knockdown would suggest this C193R mutation might be a loss of function mutation. embryos showed randomization in both embryonic turning and heart tube looping (Fig. S1 D-H and Table S4 ). We also noted an apparent shortening of the outflow tract, a phenotype reminiscent of the shortened heart tube seen in the zebrafish Megf8 morphants (Fig. 2C and Fig. S1 E and F) . The breaking of symmetry and specification of left-right patterning are largely orchestrated by the embryonic expression of the highly conserved Nodal, Lefty1/Lefy2 and Pitx2 signaling network early in embryogenesis, largely spanning E7.75-8.5 (13) . Notably, Megf8 is not asymmetrically expressed, because RNA in situ hybridization analysis with 2 independent Megf8 probes showed Megf8 transcripts are ubiquitously expressed in the embryo (Fig. S4 ). This same pattern was observed in wild-type and Megf8 m/m mutant embryo (Fig. S4 ). An early molecular evidence of left-right asymmetry is the transient asymmetry in Nodal expression at the embryonic node. Analysis of Megf8 m/m mutants showed 3 of 7 embryos with stronger left sided perinodal expression of Nodal (Fig. 3B ). This compared with 3 of 5 wild-type/heterozygous embryos exhibiting stronger left sided Nodal expression at the node (Fig. 3A) . These results suggest the breaking of symmetry at the node is unaffected. Consistent with this, motile function associated with monocilia at the node, which is required for breaking symmetry (14) , was also preserved (Fig. S5 and Quicktime Movie S1 and Movie S2).
Thus, Megf8 m/m embryos exhibited normal clockwise ciliary rotation with a beat frequency indistinguishable from heterozygous and wild-type embryos. Using fluorescent beads, we also examined cilia generated flow at the node and again, no change was detected (Fig. S5 ). These findings suggest Megf8 functions downstream of the node. Indeed, in situ hybridization analysis of Megf8 m/m embryos showed Nodal expression, although intact at the node, was absent in the left LPM (n ϭ 7, 3-4 somites) (Fig.  3B) . Expression of genes downstream of Nodal was also disrupted, with Lefty1 and Lefty2 expression lost in the floor plate and LPM, respectively (n ϭ 5, 4-5 somites, Fig. 3D ). Pitx2 expression in the LPM was either absent (n ϭ 2) or bilateral (n ϭ 5) (6-8 somites) (Fig. 3 G-I ). In contrast, Pitx2 expression in the head mesenchyme was unaffected.
Genetic analyses have suggested that Nodal expression at the node is required for the activation of left-determinant transcription cascade in the left LPM (15, 16) . Our data, would suggest the molecular defect underlying the Megf8 m/m phenotype is either an interruption of signal transfer from the node to left LPM and/or a disruption in the initiation and expansion of Nodal expression in the LPM. To further elucidate the underlying molecular mechanism, we examined the expression of Gdf1 and Cryptic. Gdf1 encodes a TGF␤ superfamily ligand required for Nodal long-range action, including propagation of Nodal signaling from the embryonic node to the LPM (17), while Cryptic, a coreceptor required for Nodal signal reception, is also essential for Nodal expression in the left LPM (18) Morpholino knockdown of Megf8 causes situs discordance of heart tube and foregut. Zebrafish embryos injected with control or Megf8 morpholinos were examined for heart and gut situs defects using RNA in situ hybridization analysis with Nkx2.5 (A-D) and Foxa3 (E-H) probes to visualize the heart tube and gut, respectively. In the majority of zebrafish embryos injected with control morpholino, the heart tube exhibited normal rightward looping delineating a S-shaped heart tube (A), whereas the foregut showed normal leftward looping (E). Megf8 morpholino injection resulted in randomization of the direction of looping for both the heart tube (B-D) and foregut (F-H). 3 E, F, J, and K), suggesting Megf8 regulation of Nodal signaling does not involve the modulation of Gdf1 and Cryptic expression.
Punctate Nuclear Localization of Megf8. To further explore the possible function of Megf8, we generated an antibody to Megf8 to investigate its subcellular distribution. Although Megf8 is predicted to have a transmembrane domain, immunostaining and confocal imaging showed no cell surface localization in either mouse embryonic fibroblasts (MEFs) or NIH 3T3 cells. Instead, we observed prominent punctate nuclear staining and varying levels of cytoplasmic staining (Fig. 4 D-F) . Immunostaining of embryo cryosections showed a similar distribution, including punctate nuclear localization (Fig. 4 A-C) . No obvious change in Megf8 expression level or distribution was observed in either Megf8 m/m embryos or MEFs derived from the mutant embryos (Fig. S6) . The specificity of the Megf8 antibody was verified with Megf8 siRNA knockdown, which largely abolished the Megf8 antibody staining (Fig. S6 ). In addition, Western immunoblotting of transfected cells expressing a C-terminal 3XFLAG-tagged Megf8 fusion protein gave an expected high molecular weight band that was detected by both the Megf8 and FLAG antibodies (Fig. S7) . The finding of Megf8 localization in the nucleus was particularly interesting in light of a previous report from a yeast 2-hybrid screen that identified Megf8 as a potential interacting partner of Gfi1b (19), a nuclear protein with known transcription repressor activity and a role in heterochromatinization in erythroid cell lineages (20, 21) . Double immunostaining showed Megf8/Gfi1b are colocalized as punctate spots in the nucleus (Fig. 4 D and E) . Unlike the localization seen in erythroid progenitors, in MEFs and NIH 3T3 cells, Gfi1b and Megf8 were not concentrated in heterochromatic regions delineated by strong DAPI staining (Fig. 4 E and F) . Further analysis showed Megf8 m/m mutants, unlike Gfi1b knockout mouse embryos (20), do not have defects in definitive erythropoeisis (Fig. S8) 
Interestingly, a chromatin remodeling protein, Baf60C, a component of the Swi/Snf-like BAF complex, also has been shown to play an essential role in left-right patterning, with the Baf60C knockdown mice exhibiting cardiac and laterality phenotypes very similar to the Megf8 m/m mutants (22) (Fig. 4 G-J) . Together these findings suggest Megf8 may regulate Nodal signaling through a role in chromatin remodeling.
Discussion
Recovery of ENU-Induced Mutations by Massively Parallel Sequencing.
Using massively parallel sequencing, we identified 2 singlebase substitutions in a 2.2-Mb genomic interval containing an ENU-induced mutation causing heterotaxy. This is the first demonstration of the use of massively parallel sequencing in the recovery of ENU-induced mutations. We used a strategy combining both massively parallel sequencing and BAC contig construction to recover the ENU-induced mutations. This strategy obviated the presently prohibitive expense entailed in whole genome resequencing. By sequencing only a subset of the genome contained within the BAC contig, we also minimized potential complications from segmental duplications and repeat sequences in the mouse genome. Using BLAT analysis for sequence alignment, we obtained 10 mismatch calls in the 2.2-Mb genomic interval relative to the C57BL6J reference sequence, only 2 of which were corroborated as real mutations by Sanger sequencing. These results indicate refinement of the calling algorithms is needed before base calling for whole genome resequencing can be automated. Significant technical challenges also remain in the development of sequence alignment algorithms that can automate the assembly of short reads in whole genome sequencing projects when repeat sequences and segmental duplications are unavoidable.
We identified a single C to T base change (C193R) causing a cysteine to arginine substitution in the coding region of Megf8. In addition, a second C to A base change was found in a noncoding intergenic region in the mapped interval. These results are remarkably in line with previous estimate of one ENU-induced mutation per Mb, with one in 1.82 Mb expected to alter function (23) . We note Megf8 was not yet annotated in the mouse genome when this mutation was first mapped to mouse chromsome 7. Thus, a candidate gene sequencing strategy at that time would have failed to recover the mutation. We note with the recent emergence of sequence capture technology, targeted genome sequencing may be feasible without the expense entailed in BAC library construction (24, 25) . Moreover, with the rapid decline in the cost of massively parallel sequencing, and the advent of real time single-molecule DNA sequencing technology (26) , whole genome resequencing may be on the horizon, making the recovery of ENU-induced mutations affordable and straight forward.
Role of Megf8 in Left-Right Patterning. Our studies show an essential role for Megf8 in left-right patterning. Current model for left-right patterning suggests 4 discrete steps in left-right specification: first is the breaking of symmetry at the embryonic node, second is transfer of asymmetric signal from the node to the left LPM, third is Nodal-activated transcription of left-determinant genes such as Pitx2 and Lefty, and 4th is the final asymmetric elaboration of organogenesis (13, 27) . in the LPM, and Pitx2 expression was either absent or bilateral. The discordance in Pitx2 and Nodal expression in our mutant is reminiscent of previous studies showing the uncoupling of Nodal and Pitx2 expression in zebrafish embryos (28) and in various mutant mouse models, such as the polycystin-2 knockout mice (29) . It is interesting to note that polycystin-2, like Megf8 is also ubiquitously expressed, and polycystin-2 knockout mutants show normal node expression of Nodal, but largely absent Nodal expression in the LPM. These findings suggest additional levels of complexities beyond the central Nodal signaling cascade in the specification of laterality. Overall, these findings show Megf8 is required, not for the initial breaking of symmetry, but in subsequent steps to initiate Nodal expression in the left LPM. The finding of prominent Megf8 colocalization with Gfi1b and Baf60C in the nucleus suggests a role in the regulation of gene expression in the left LPM through chromatin remodeling. Baf60c was shown to regulate left-right asymmetry through Notch-dependent transcription around the node (22) . However, unlike Baf60C mutants, in situ hybridization showed no change in perinodal Notch1 or Delta1 expression in Megf8 m/m mutants (Fig. S4) , whereas Baf60C mutants, unlike Megf8 m/m mutants, exhibit little or no expression of Nodal at the embryonic node. Because Baf60c is also expressed in the LPM, Baf60c and Megf8 could potentially act in the same chromatin remodeling complex to promote Nodal-driven asymmetric transcription in the LPM, either downstream of or in a pathway parallel to Notch-dependent regulation of leftright patterning.
Alternatively, Megf8 may regulate left-right patterning by facilitating the transfer of Nodal from the embryonic node to the left LPM. The long-range action of Nodal has been shown to require the formation of Nodal-Gdf1 heterodimers (17) . Recent studies also suggest the interaction of Nodal and sulfated glycosaminoglycans (GAGs) play a role in the longrange propagation of Nodal signaling (30) . The predicted protein structure of Megf8, which includes a transmembrane domain and many EGF repeats in the presumptive extracellular domain, would suggest it might function as a protein scaffold for GAGs or directly interact with Nodal or Gdf1 to stabilize Nodal-Gdf1 heterodimers. Although we failed to observe Megf8 immunolocalization at the cell surface, we cannot exclude a shorter Megf8 isoform being localized at the cell surface, because the Megf8 antibody was made using a peptide toward the N terminus. Similarly, it is possible that cleaved and secreted N-terminal Megf8 might play a role in Nodal-Gdf1 heterodimer transfer. Further studies are needed in the future to define the precise function of Megf8, including the analysis of conditional knockout mouse models to define the cell lineage requirement for Megf8 and its role in cardiac morphogenesis. Because Megf8 mutants also exhibit preaxial polydactyly, it is possible that Megf8 may have additional independent roles in other aspects of embryonic development.
Materials and Methods
Mutation Mapping. The mutation was mapped to a 3.3-Mb region of chromosome 7 between markers D7mit192 and D7mit266 (11) . Further fine mapping was carried out using SNPs or microsatellite markers within the mapped interval that are polymorphic between C57BL/6J and C3H or A/J, and tracking the segregation of C57BL6 markers.
BAC Library Construction, Screening, and Sequencing. CHORI-602 BAC library construction was constructed as described in ref. 31 . Briefly, DNA from a single homozygous mouse embryo was partially digested with EcoRI and cloned into the BAC vector pTARBAC2.1. Forty-four pairs of radiolabeled unique overlapping oligonucleotides (overgos) were used to screen the BAC library and172 BAC clones were identified as having genomic fragments in the critical region. Positive BAC clones were end-sequenced to locate genomic fragment boundary and 139 BACs were positively mapped to the critical region by end sequencing, and 15 overlapping BAC clones were identified comprising the minimal tiling path. Each BAC was independently isolated by standard alkaline lysis (Qiagen) and equimolar amounts of each BAC were pooled for standard Illumina Genome Analyzer I sequencing.
Videomicroscopy of Nodal Ciliary Motion. E7.5-E7.75 embryos were dissected and transferred node side down onto 35-mm glass-bottomed culture dishes. Videomicroscopy was carried out using a Leica DMIRE2 inverted microscope with a Phantom v4.2 camera (Vision Research). To quantify nodal flow, a small quantity of 0.20 m Fluoresbrite microspheres (Polysciences) were added to the media bathing the node and fluorescent movies were collected using a cooled low light CCD camera (Hamamatsu; C9100-12). Volocity 3.5.1 software (Perkin-Elmer) was used to analyze speed and directionality of microsphere movement.
Zebrafish Morpholino Injections. Two antisense morpholino oligonucleotides (Megf8moE1 and Megf8moE2, Gene Tools) to Megf8 were designed as illustrated in Fig. S3A . The standard negative control morpholino was provided by Gene Tools. Increasing doses (0.5 pmol to 4.0 pmol) were injected into 1-cellstage embryos to determine optimal concentrations. At 48 h after fertilization, embryos were scored for the direction of heart looping or collected and fixed for in situ hybridization.
In Situ Hybridization Analysis. Whole mount RNA in situ hybridization was performed as described in ref. 32 , using a robot (Intavis AG) with DIGlabeled probes for zebrafish Nkx2.5 and Foxa3, and mouse Nodal, Lefty1, Lefty2, Pitx2, Cryptic, Gdf1, Notch, and Delta2. Megf8 in situ hybridization probes were generated using PCR amplification with probe 1 generated using forward (5ЈCAACTACAGCGTCAACGGCAAC) and reverse (5Ј TCACAGGCTCGTCCCAA-GAATC) primers, and probe 2, with forward (5Ј ACCCTTGAGCCCACAGAAGATG) and reverse (5ЈCGTGATAAGACAAACCGCTTCCAG) primers.
Immunostaining. Polyclonal antibody to Megf8 was raised in chickens by immunization with the synthetic peptide QQEKETRRLQRPGSDR corresponding to amino residues 775 to 790 at the N terminus of Megf8 (Aves Labs). The antibody was affinity purified and analyzed by ELISA. For immunostaining, cells were fixed in 4% paraformaldehyde at room temperature or embryos similarly fixed were cryoembedded and sectioned. Other primary antibodies used included goat anti-Gfi-1B (Clone D-19, 1:50; Santa Cruz), and mouse anti-SMARCD3 (1:100, clone 1G6; Abnova). Imaging was carried out using Zeiss LSM 510 META confocal microscope or a Leica DMRE microscope. Images were deconvolved using Openlab and Volocity imaging software.
Western Blot Analysis. A Megf8 fusion construct was generated by adding a 3XFLAG tag to the C terminus of full length Megf8 (GenBank accession no. EU723517) in p3XFLAG-CMV-14 expression vector (Sigma). NIH 3T3 cells transfected with this construct were lysed in RIPA buffer with 1% protease inhibitor mixture (Sigma P8340). Electrophoresis was carried out on 4 -12% polyacrylamide NuPAGE Bis-Tris denaturing gels (Invitrogen) under reducing conditions. Proteins were transferred to nitrocellulose membranes and immunodetected using the Odyssey Infrared Imaging System (LI-COR Biosciences). Primary antibodies included chicken anti-Megf8 (1:5000, Aves Labs) and mouse anti-FLAG M2 (1:1,000; Sigma), with detection carried out using secondary antibodies: goat anti-mouse IgG IR700dx (1:10,000, Rockland) and goat anti-chicken IgY IR800 (1:10,000, Rockland).
Megf8
Knockdown. For shRNA mediated knockdown, cells were transiently transfected with SureSilencing shRNA plasmids for mouse Megf8 containing a GFP reporter (SABiosciences) using Lipofectamine LTX (Invitrogen). The insert sequences were: 1, ACAGGCTACACCATGGACAAT; 2, TCACCGCCTGG-GACATACTAT; 3, CTAGGTTGGTGTGTGCACAAT; 4, ACCCTTGAGCCCACAGAA-GAT; and scrambled sequence control, GGAATCTCATTCGATGCATAC. Cells were fixed and examined after Megf8 antibody staining at 24 to 48 h after transfection. (B) Both Megf8 morpholinos disrupt heart looping. Injected and uninjected embryos were visually scored for the direction of heart looping. Normal orientation of heart looping was frequently observed in uninjected embryos (n ϭ 168), but not in embryos injected with either Megf8moE1 (n ϭ 92) or Megf8moE2 (n ϭ 123) morpholino. These injections were not included in the results shown in the bar graph of Fig. 1C , for which heart and gut looping were scored using in situ hybridization markers. Megf8 with a C-terminal 3XFLAG tag showed a band Ͼ300 kDa (see arrow), in the size range expected for the Megf8 fusion protein. This same band was detected simultaneously with both the FLAG (red) and Megf8 (green) antibodies using 2 color Western immunodetection. Fig. S8 . Analysis of definitive erythropoeisis in Megf8 mutant embryos. To determine if Megf8 mutant embryos have a defect in definitive erythropoeisis, blood smears were made with blood collected from the umbilical vessels of E15-E18 stage embryos. After air drying, followed by 2-minute fixation in 100% methanol, the blood smears were mounted using DAPI containing Vectashield mounting medium (Vector Laboratories), and the percentage of nucleated RBCs was quantitated. The percentage of nucleated RBCs declined from E15 until none were detected near-term at E17.5 and beyond. This was observed for all 3 genotypes (WT, heterozygous, and homozygous Megf8 mutants), consistent with normal transition to definitive erythropoiesis. These findings suggest Megf8 mutants have no defect in definitive erythropoiesis. 
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